Differences in the prevalence of metabolic syndrome in urban and rural India: a problem of urbanization

Abstract

Get full access to this article

View all access options for this article.

References

Yusuf S. , Reddy S. , Ounpuu S. , Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies . Circulation 2001; 104: 2855—64.

Yusuf S. , Reddy S. , Ounpuu S. , Anand S. Global burden of cardiovascular diseases: Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746—53.

Reddy KS , Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596—601.

Shetty P. , Iyengar V. , Sawaya A. , et al. Application of stable isotopic techniques in the prevention of degenerative diseases like obesity and NIDDM in developing societies. Food Nutr Bull 2002; 23(3 Suppl): 174—9.

Reddy KS , Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596—601.

Bahl VK , Prabhakaran D. , Karthikeyan G. Coronary artery disease in Indians. Indian Heart J 2001; 53: 703—13.

Gupta R. , Gupta VP Meta-analysis of coronary heart disease prevalence in India. Indian Heart J 1996; 48: 241—5.

Chaturvedi N. Differing aspects of insulin resistance in diabetes complications: the shape of things to come. RD Lawrence Lecture 2000. Diabetes Med 2002; 19: 973—7.

Das UN

Metabolic syndrome X is common in South Asians, but why and how?

Nutrition 2002; 18: 774—6.

10.

Hughes K. , Aw TC , Kuperan P. , Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein (a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health 1997; 51: 394—9.

11.

McKeigue PM Metabolic consequences of obesity and body fat pattern: lessons from migrant studies. Ciba Found Symp 1996; 201: 54—64.

12.

McKeigue PM , Ferrie JE , Pierpoint T. , Marmot MG Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993; 87: 152—61.

13.

Timar O. , Sestier F. , Levy E. Metabolic syndrome X: a review. Can J Cardiol 2000; 16: 779—89.

14.

Lakka HM , Laaksonen DE , Lakka TA , et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709—16.

15.

Ford ES , Giles WH , Dietz WH Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356—9.

16.

Resnick HE , Strong Heart Study Investigators. Metabolic syndrome in American Indians. Diabetes Care 2002; 25: 1246—7.

17.

Araneta MR , Wingard DL , Barrett-Connor E. Type 2 diabetes and metabolic syndrome in Filipina-American women: a high-risk nonobese population. Diabetes Care 2002; 25: 494—9.

18.

Isomaa B. , Almgren P. , Tuomi T. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683—9.

19.

Marques-Vidal P. , Mazoyer E. , Bongard V. , et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 2002; 25: 1371—7.

20.

Jia WP , Xiang KS , Chen L. , Lu JX , Wu YM Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 2002; 3: 157—65.

21.

Wu G. Further Study Of Risk Factors For Stroke And Coronary Heart Disease, The prevalence of metabolic syndrome in an 11 provinces cohort in China. Zhonghua Yu Fang Yi Xue Za Zhi 2002; 36: 298—300.

22.

Onat A. , Ceyhan K. , Basar O. , Erer B. , Toprak S. , Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels — a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165: 285—92.

23.

Ramachandran A. , Snehalatha C. , Satyavani K. , Sivasankari S. , Vijay V. Metabolic syndrome in urban Asian Indian adults — a population study using modified ATP III criteria. Diabetes Res Clin Pract 2003; 60: 199—204.

24.

The Task Force Study on Coronary Heart Diseases in India. Project. No. 1988-0608A. New Delhi: Indian Council of Medical Research, 1994.

25.

World Health Organization. WHO Consultation on Obesity. Obesity: preventing and managing the global epidemic . WHO Technical Report Series 894. Geneva: WHO, 2000.

26.

Choo V. WHO reassesses appropriate body-mass index for Asian populations. Lancet 2002; 360: 235.

27.

Census of India 1991. Provisional population totals and rural/urban distribution. Paper 2 of 1991. New Delhi: Registrar General of India, 1991.

28.

Census of India 1991. Final population tables . Paper 2 of 1992. New Delhi: Registrar General of India, 1992.

29.

Reddy KS , Prabhakaran D. , Shah P. , Shah B. Differences in body mass index and waist:hip ratios in North Indian rural and urban populations. Obes Rev 2002; 3: 197—202.

30.

Prabhakaran D. , Anand SS The metabolic syndrome: an emerging risk state for cardiovascular disease. Vasc Med 2004; 9: 55—68.

31.

Gupta R. , Deedwania PC , Gupta A. , Rastogi S. , Panwar RB , Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 2004; 97: 257—61.

32.

Ozsahin AK , Gokcel A. , Sezgin N. , et al. Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab 2004; 17: 230—4.

33.

Martinez-Larrad MT , Fernandez-Perez C. , Gonzalez-Sanchez JL , et al. Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia. Med Clin (Barc) 2005; 125: 481—6.

34.

Abdul-Rahim HF , Husseini A. , Bjertness E. , Giacaman R. , Gordon NH , Jervell J. The metabolic syndrome in the West Bank population: an urban— rural comparison. Diabetes Care 2001; 24: 275—9.

35.

Tillin T. , Forouhi N. , Johnston DG , McKeigue PM , Chaturvedi N. , Godsland IF Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 2005; 48: 649—56.

36.

Palaniappan L. , Carnethon MR , Wang Y. , et al. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27: 788—93.

37.

Park YW , Zhu S. , Palaniappan L. , Heshka S. , Carnethon MR , Heymsfield SB The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988—1994. Arch Intern Med 2003 ; 163: 427—36.

38.

Azizi F. , Salehi P. , Etemadi A. , Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003 ; 61: 29—37.

39.

Tuomilehto J. , Lindstrom J. , Eriksson JG , et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343—50.

40.

Knowler WC , Barrett-Connor E. , Fowler SE , et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 ; 346: 393—403.

41.

Reddy KS , Prabhakaran D. , Chaturvedi V. , et al. Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull World Health Organ 2006; 84: 461—9.

42.

Gupta R. , Gupta HP , Keswani P. , Sharma S. , Gupta VP , Gupta KD Coronary heart disease and coronary risk factor prevalence in rural Rajasthan . J Assoc Physicians India 1994; 42: 24—6.